Rhizen Pharmaceuticals (Switzerland)

Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study

Howard A. Burris, Ian W. Flinn, Manish R. Patel et al. · The Lancet Oncology · 2018 · 202 citations

Hematological Malignancy, Tumor Biology, Lymphoid Neoplasia +10

Extracts of Momordica charantia Suppress Postprandial Hyperglycemia in Rats

Takashi Uebanso, Hidekazu Arai, Yutaka Taketani et al. · Journal of Nutritional Science and Vitaminology · 2007 · 78 citations · Full text

Nutrition, Glycobiology, Immunology +19

Antithrombotic Effects of Odorless Garlic Powder Both<i>in Vitro</i>and<i>in Vivo</i>

Hideharu Fukao, Hideki Yoshida, Yoh-ichi TAZAWA et al. · Bioscience Biotechnology and Biochemistry · 2007 · 64 citations · Full text

Thrombosis, Odorless Garlic Powder, Hematology +19

Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma

Auris Huen, Bradley M. Haverkos, Jasmine M. Zain et al. · Cancers · 2020 · 62 citations · Full text

Conjugated Docosahexaenoic Acid Is a Potent Inducer of Cell Cycle Arrest and Apoptosis and Inhibits Growth of Colo 201 Human Colon Cancer Cells

Naoyuki Danbara, Takashi Yuri, Miki Tsujita‐Kyutoku et al. · Nutrition and Cancer · 2004 · 50 citations